ARWR Arrowhead Pharmaceuticals, Inc.
62.35USD-2.87%Mkt Cap: 8.78B $P/E: —1d ago
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasir…
Industry Peers
Biotechnology$127.54BUSDP/E 29.3
$81.13BUSD
$74.79BUSDP/E 18.0
$57.11BUSDP/E 34.8
$55.24BUSDP/E 36.1
$44.51BUSD
$41.63BUSDP/E 17.7
$41.14BUSDP/E 64.7
$32.74BUSDP/E 30.1
$29.42BUSDP/E 37.1
$25.84BUSD
$24.53BUSD
$24.01BUSDP/E 30.3
$23.13BUSDP/E 14.5
$22.67BUSD
$21.61BUSDP/E 29.3
$15.32BUSDP/E 16.2
$15.01BUSDP/E 17.5
$14.58BUSDP/E 18.6
$13.78BUSD
Key Statistics
Company
Market Cap8.78B USD
Enterprise Value8.85B USD
Revenue (TTM)669.49M USD
Gross Profit669.49M USD
Net Income (TTM)-1.63M USD
Revenue/Share4.77 USD
Last Price62.35 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees711
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.02
PEG—
EV/EBITDA-44.11
EV/Revenue13.22
P/S13.51
P/B19.46
EPS (TTM)-2.28
EPS (Forward)-4.93
52W Range
31.4548% of range95.49
52W High95.49 USD
52W Low31.45 USD
Profitability
Gross Margin100.00%
Oper. Margin-226.03%
EBITDA Margin-29.97%
Profit Margin-0.20%
ROE-0.35%
ROA-0.12%
Growth
Revenue Growth171.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF179.55M USD
CapEx (TTM)22.67M USD
FCF Margin-7.26%
FCF Yield-0.55%
Net Debt-218.45M USD
Net Debt/EBITDA1.09
Balance Sheet
Debt/Equity0.79
Current Ratio5.90
Quick Ratio5.71
Book Value/Sh3.30 USD
Cash/Share11.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateNov 17, 2011
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)107.23 USD
Upside (mean)+72.0%
Target Range74.00 USD – 126.00 USD
74.00+72.0% to mean126.00
# Analysts13
Ownership
Shares Out.140.86M
Float122.45M
Insiders3.66%
Institutions85.44%
Short Interest
Short Ratio6.4d
Short % Float9.13%
Short % Out.6.56%
Shares Short9.27M
Short (prev mo.)9.21M
Technical
SMA 5080.81 (-22.8%)
SMA 20072.49 (-14.0%)
Beta1.28
S&P 52W Chg14.58%
Avg Vol (30d)1.76M
Avg Vol (10d)2.05M
Technical Indicators
RSI (14)27.1
MACD-5.3269
MACD Signal-4.6450
MACD Hist.-0.6818
BB Upper90.18 USD
BB Middle72.60 USD
BB Lower55.03 USD
BB Width48.41%
ATR (14)3.369 USD
Vol Ratio (20d)1.06x